DE2617738C2 - - Google Patents

Info

Publication number
DE2617738C2
DE2617738C2 DE2617738A DE2617738A DE2617738C2 DE 2617738 C2 DE2617738 C2 DE 2617738C2 DE 2617738 A DE2617738 A DE 2617738A DE 2617738 A DE2617738 A DE 2617738A DE 2617738 C2 DE2617738 C2 DE 2617738C2
Authority
DE
Germany
Prior art keywords
acid
methyl
dihydrolysergic
lysergic
amide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2617738A
Other languages
German (de)
English (en)
Other versions
DE2617738A1 (de
Inventor
Geb. Karacsony Erzsebet Mago
Jozsef Dr. Borsi
Laszlo Dr. Tardos
Ildiko Dr. Kiraly
Sandor Dr. Elek
Istvan Dr. Budapest Hu Elekes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of DE2617738A1 publication Critical patent/DE2617738A1/de
Application granted granted Critical
Publication of DE2617738C2 publication Critical patent/DE2617738C2/de
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06Lysergic acid amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE19762617738 1975-04-24 1976-04-23 Lysergsaeureamide, solche enthaltende arzneimittel sowie verfahren zur herstellung derselben Granted DE2617738A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU75GO00001309A HU172649B (hu) 1975-04-24 1975-04-24 Sposob poluchenija novykh biologicheski aktivnykh lizergamidov

Publications (2)

Publication Number Publication Date
DE2617738A1 DE2617738A1 (de) 1976-11-18
DE2617738C2 true DE2617738C2 (US20110158925A1-20110630-C00042.png) 1989-10-19

Family

ID=10996791

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762617738 Granted DE2617738A1 (de) 1975-04-24 1976-04-23 Lysergsaeureamide, solche enthaltende arzneimittel sowie verfahren zur herstellung derselben

Country Status (21)

Country Link
US (1) US4101552A (US20110158925A1-20110630-C00042.png)
JP (1) JPS5940833B2 (US20110158925A1-20110630-C00042.png)
AT (1) AT352297B (US20110158925A1-20110630-C00042.png)
AU (1) AU503465B2 (US20110158925A1-20110630-C00042.png)
BE (1) BE841049A (US20110158925A1-20110630-C00042.png)
BG (1) BG33885A3 (US20110158925A1-20110630-C00042.png)
CA (1) CA1081215A (US20110158925A1-20110630-C00042.png)
CH (1) CH619708A5 (US20110158925A1-20110630-C00042.png)
CS (1) CS194758B2 (US20110158925A1-20110630-C00042.png)
DD (1) DD125487A5 (US20110158925A1-20110630-C00042.png)
DE (1) DE2617738A1 (US20110158925A1-20110630-C00042.png)
DK (1) DK144127C (US20110158925A1-20110630-C00042.png)
FR (1) FR2308366A1 (US20110158925A1-20110630-C00042.png)
GB (1) GB1512874A (US20110158925A1-20110630-C00042.png)
HU (1) HU172649B (US20110158925A1-20110630-C00042.png)
IL (1) IL49447A (US20110158925A1-20110630-C00042.png)
NL (1) NL7604266A (US20110158925A1-20110630-C00042.png)
PL (1) PL102509B1 (US20110158925A1-20110630-C00042.png)
SE (1) SE425783B (US20110158925A1-20110630-C00042.png)
SU (1) SU604493A3 (US20110158925A1-20110630-C00042.png)
YU (1) YU42144B (US20110158925A1-20110630-C00042.png)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2802023A1 (de) * 1977-01-28 1978-08-03 Sandoz Ag Neue ergotderivate, ihre herstellung und verwendung
GB1584464A (en) * 1977-04-19 1981-02-11 Farmaceutici Italia Ergot alkaloids
IT1192260B (it) * 1977-07-05 1988-03-31 Simes Derivati di ergoline-2-tioeteri e loro solfossidi
AU553809B2 (en) * 1981-07-21 1986-07-31 Farmitalia Carlo Erba S.P.A. Ergoline derivatives
CH653333A5 (de) * 1981-11-04 1985-12-31 Sandoz Ag N-substituierte ergolin- und 9,10-didehydroergolinderivate, ihre herstellung und sie enthaltende arzneimittel.
YU254782A (en) * 1981-12-18 1986-10-31 Schering Ag Process for making new ergot anilides
DE91652T1 (de) * 1982-04-13 1984-03-29 Farmitalia Carlo Erba S.p.A., 20159 Milano Ergolinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
GB2173189B (en) * 1985-02-21 1988-04-27 Maruko Pharmaceutical Co Ergoline derivatives and salts thereof and pharmaceutical compositions thereof
US4910206A (en) * 1986-07-14 1990-03-20 Sandoz Pharmaceuticals Corp. 5-hetero-or aryl-substituted-imidazo(2,1-a)isoquinolines and their use as PAF receptor antagonists
US4902691A (en) * 1988-12-19 1990-02-20 Eli Lilly And Company Heteroalkylamides of (8-β)-1-alkyl-6-(substituted)ergolines useful for blocking 5HT2 receptors
WO2016118541A1 (en) * 2015-01-20 2016-07-28 Xoc Pharmaceuticals, Inc Ergoline compounds and uses thereof
BR112019025420A2 (pt) 2017-06-01 2020-06-16 Xoc Pharmaceuticals, Inc. Compostos policíclicos e usos destes
EP3941583B9 (en) 2020-06-12 2023-04-19 Beckley Psytech Limited Composition comprising a benzoate salt of 5-methoxy-n,n-dimethyltryptamine
GB202212116D0 (en) 2022-08-19 2022-10-05 Beckley Psytech Ltd Pharmaceutically acceptable salts and Compositions thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2090430A (en) * 1937-08-17 Lysergic acid amides and process for
US2736728A (en) * 1954-12-06 1956-02-28 Lilly Co Eli Preparation of lysergic acid amides
DE1040560B (de) * 1955-11-21 1958-10-09 Lilly Co Eli Verfahren zur Herstellung von Lysergsaeureamiden
US2997470A (en) * 1956-03-05 1961-08-22 Lilly Co Eli Lysergic acid amides
GB1112909A (en) * 1964-09-15 1968-05-08 Sandoz Ltd Ergoline derivatives
CH496010A (de) * 1967-04-20 1970-09-15 Richter Gedeon Vegyeszet Verfahren zur Herstellung von d-Lysergsäureamiden
SE396753B (sv) * 1970-05-18 1977-10-03 Richter Gedeon Vegyeszet Analogiforfarande for framstellning av en forening tillhorande dihydrolysergsyraserien
IL41409A (en) * 1972-02-04 1977-04-29 Richter Gedeon Vegyeszet Lysergic acid amides and process for their preparation
HU169073B (US20110158925A1-20110630-C00042.png) * 1974-05-28 1976-09-28

Also Published As

Publication number Publication date
IL49447A (en) 1979-11-30
DK144127B (da) 1981-12-14
NL7604266A (nl) 1976-10-26
JPS5940833B2 (ja) 1984-10-03
US4101552A (en) 1978-07-18
CS194758B2 (en) 1979-12-31
BG33885A3 (en) 1983-05-16
FR2308366B1 (US20110158925A1-20110630-C00042.png) 1978-12-08
YU103176A (en) 1982-08-31
YU42144B (en) 1988-06-30
BE841049A (fr) 1976-10-25
GB1512874A (en) 1978-06-01
JPS51131898A (en) 1976-11-16
DD125487A5 (US20110158925A1-20110630-C00042.png) 1977-04-20
DK184176A (da) 1976-10-25
AU503465B2 (en) 1979-09-06
CH619708A5 (US20110158925A1-20110630-C00042.png) 1980-10-15
SE7604724L (sv) 1976-10-25
DK144127C (da) 1982-06-01
FR2308366A1 (fr) 1976-11-19
SE425783B (sv) 1982-11-08
CA1081215A (en) 1980-07-08
AU1328376A (en) 1977-10-27
DE2617738A1 (de) 1976-11-18
SU604493A3 (ru) 1978-04-25
HU172649B (hu) 1978-11-28
ATA286376A (de) 1979-02-15
AT352297B (de) 1979-09-10
PL102509B1 (pl) 1979-04-30
IL49447A0 (en) 1976-06-30

Similar Documents

Publication Publication Date Title
DE2617738C2 (US20110158925A1-20110630-C00042.png)
EP0135762B1 (de) Steroide
EP0271795A2 (de) Octahydro-10-oxo-6H-pyridazo [1,2-a] [1,2] diazepin-Derivate, Zwischenprodukte und Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel
DE2523743A1 (de) Verbindungen mit ergolinstruktur, solche enthaltende arzneimittel sowie verfahren zur herstellung derselben
DE2824905A1 (de) Neue 1, 2, 3, 4, 6, 7-hexahydro-11 balphah-benzo(a)chinolizin-derivate und verfahren zur herstellung derselben
DE68910211T2 (de) Estramustin-ester.
DE2446758C3 (de) 2-(2-Fluor-6-trifluormethylphenylimino)-imidazolidin, dessen Säureadditionssalze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung der Hypertonie
DE2124640C2 (de) 1-Methyl-9,10-dihydrolysergyl-omega-nitro-L-argininol sowie seine Salze und diese Verbindungen enthaltende Arzneimittel
DE3885252T2 (de) Nichtpeptidische Renin-Hemmer.
DE1795022C3 (de) Lysergsäurederivate
DE2624789A1 (de) Eburnameninderivate und verfahren zu ihrer herstellung
DE68905363T2 (de) Heterotetracyclische laktamderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
EP0103142A1 (de) Thieno(2,3-e)-1,2-thiazin-Derivate
DE2223681A1 (de) Neue heterocyclische Verbindungen und Verfahren zu ihrer Herstellung
DE2710246A1 (de) Delta hoch 8 -ergolen- beziehungsweise ergolinderivate, solche enthaltende arzneimittel sowie verfahren zur herstellung derselben
DE2454619A1 (de) Verfahren zur herstellung neuer heterocyclischer verbindungen
EP0003286B1 (de) Ergopeptidalkaloid-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
EP0078949B1 (de) Neue 1-Furyl-3,4-dihydroisochinoline diese enthaltende Arzneimittel sowie Verfahren zu deren Herstellung und deren Verwendung
CH644120A5 (de) Ergol-8-en- und ergolin-verbindungen sowie verfahren zu ihrer herstellung.
DE2530005C3 (de) 6,11-Dihydrodibenzo [b,e] thiepin-Derivate und deren Salze, Verfahren zu ihrer Herstellung und diese Substanzen enthaltende pharmazeutische Zubereitungen
DE2638828A1 (de) Neue thieno-pyridine
DE2529792A1 (de) Antidepressive verbindungen, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2125588A1 (de) Verfahren zur Herstellung neuer heterocyclischer Verbindungen
WO1983002775A1 (en) Ergot alkaloids, manufacturing process thereof and pharmaceutical preparations containing them
EP0040685A2 (de) Lysergsäurederivate und deren pharmazeutische Zubereitungen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee